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ABSTRACT 
Trichodermamide B is an unusual modified dipeptide natural product, with very promising 
anticancer activities. While the biosynthesis of this molecule is unknown, it is proposed herein that 
it is formed in vivo through direct oxidation of phenylalanine to the arene oxide or arene dioxide 
intermediate, which is then opened via nucleophilic attack of an oxime. To probe the feasibility of 
this biosynthetic hypothesis, a series of bioinspired approaches to trichodermamide B have been 
investigated, proceeding through arene oxide equivalents. Progress towards the concise and 
practical total synthesis of this molecule are described herein. Notable transformations explored 
include the mild installation of an oxime with hydrogen atom transfer, and microbial arene 
oxidation to generate decagram amounts of enantiopure, value-added starting materials. This 
strategy has enabled rapid access to large quantities of advanced intermediates, and once complete, 
should afford the natural product as a single enantiomer in far fewer steps than previously reported.  
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CHAPTER 1: INTRODUCTION 
1.1 Isolation and Structure of the Trichodermamides. 
The trichodermamides are a small family of modified dipeptide natural products, produced 
by the marine-dwelling cosmopolitan fungus Trichoderma virens. Trichodermamides A and B (1, 
2) were first isolated from T. virens in 2003;1 trichodermamide C (3) has since been found in the 
terrestrial fungus Eupenicillium sp.2 These compounds are notably similar, exhibiting significant 
structural homology. They are characterized by a cis-oxazadecalin core decorated with four 
contiguous stereocenters, joined to an aminocoumarin fragment through an amide bond. Across 
the series, these molecules only differ at the substitution of two positions: the amide nitrogen and 
the allylic alcohol or chloride (Figure 1).  
 
 
What is structurally most intriguing about the trichodermamides is the central cis-
oxazadecalin core – a motif that is only found in a select few natural products. The first report of 
a 5,6-dihydro-1,2-oxazine ring system such as this came in 1982, with the discovery of gliovirin 
(4).3 Interestingly, gliovirin displays many structural homologies with the trichodermamide series, 
potentially indicating that these compounds arise through similar mechanisms. Since this initial 
report, a number of molecules in the related penicillazine4 (5) and aspergillazine5 (6) class have 
been characterized, again with the same unusual 1,2-oxazine-cyclohexene subunit decorated with 
Figure 1. The trichodermamide family of natural products. 
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four contiguous stereocenters (Figure 2). Additionally, several molecules known as the 
pretrichodermamides have been isolated as potential precursors, and subsequently transformed 
into the corresponding trichodermamides.6,7  
  
 
1.2 Biological Activity of Trichodermamide B. 
 Trichodermamide B is an example of an elusive, yet extremely bioactive natural product. 
From 15 L of fermentation material, the isolation chemists were only able to gather less than 2 mg 
of the natural product. A select few bioassays were performed, wherein trichodermamide B proved 
to be a potent cytotoxic agent against human colon cancer cell line HCT-116 (IC50 of 0.32 µg/mL), 
and a powerful antimicrobial against multi-drug resistant bacterial strains, including amphotericin-
resistant C. albicans, methicillin-resistant S. aureus, and vancomycin-resistant E. faecium, with 
minimum inhibitory concentrations (MIC) of approximately15 µg/mL. While trichodermamide B 
displayed extraordinary bioactivity, trichodermamide A appeared inactive against the cell lines 
tested.1 This indicates that the allylic chloride functionality plays an important role in the biological 
activity of trichodermamide B. Interestingly, trichodermamide C, with its methylated amide 
nitrogen, also showed promising activity against HCT-116 human colon carcinoma cells, with an 
IC50 value of 0.68 μg/mL.2 This implies that substitution at the amide nitrogen might also be 
Figure 2. Structures of gliovirin, penicillazine, and aspergillazine A, other cis-fused 1,2-oxazine 
core-containing natural products.  
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important for biological activity, potentially enabling a different mechanism of action than 
trichodermamide B. 
 These initial bioactivity studies sparked much interest in the chemical community, and 
different mechanisms of action have been proposed. Clardy et al. suggested in their initial isolation 
paper that the chlorohydrin moiety of trichodermamide B served as an important precursor to an 
epoxide, which would then be the actual biologically active form of the molecule.1 Extensive 
studies by Larionov et al. however have shed some further light on the mechanism of action, 
arguing against the idea of an epoxide active species.8  
 
 
 
 
 
 
 
Examining trichodermamide B and a series of analogs, the Larionov group deduced that 
the compounds in Figure 3 displayed cytotoxic and antiproliferative activities against HeLa cells. 
The most potent of the isolated natural products was trichodermamide B, as shown previously, 
with an IC50 value of 3.1 ± 0.5 µM, and the most potent analog was epoxy-ketone 10, with an even 
lower IC50 value of 1.4 ± 0.1 µM. Concentration-response curves for 2 and the analogs displayed 
an interesting result: while the concentration-response curve for trichodermamide B was biphasic, 
Figure 3. Trichodermamide B and selected analogs studied by Larionov and coworkers. 
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the curves for each of the analogs was monophasic, suggesting potential differences in mechanism 
of action. Cellular persistence studies showed that 2 completely inhibited the formation of 
colonies, and eneone 9 showed significant inhibition, while other analogs screened displayed only 
small degrees of inhibition.8  
To assay whether compounds 2 and 7 – 10 engage targets involved in normal cell cycle 
progression, as is frequently seen with anticancer drugs, flow cytometry was used to evaluate the 
effects of these molecules on HeLa cell cycle distribution. Trichodermamide B caused 
accumulation of cells in the S phase of the cell cycle. Eneone 9 caused accumulation of cells in 
the G2/M phase, while the other analogs showed no significant effects on cell cycle distribution. 
After further studies, it was determined that trichodermamide B causes DNA damage by cleaving 
double-stranded DNA, leading to S-phase arrest. With these data it became clear that while 
compounds 2 and 7 – 10 all display antiproliferative and cytotoxic effects (in HeLa cells) with 
relatively similar potencies, there are striking differences between their mechanisms of action, 
which show no consistent pattern between simplicity of structure and activity (7 is more active 
than its simplified analog 9; 10 is extremely potent, but adding the additional ring system oblates 
activity in these studies).8 An even more recent study by the Fernandez group also showed that 
analogs of the trichodermamides reduce the inflammatory response of microglia in a manner that 
could indicate them as potential treatments for Alzheimer’s Disease.9 
These reports represent significant advances in the understanding of trichodermamide B’s 
mechanism of activity and target, however there are many remaining gray areas regarding the 
bioactivity of this fascinating molecule, which certainly warrant further investigation. To date, no 
published synthesis of trichodermamide B has been able to produce this molecule on a multigram-
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scale, thus limiting the studies that can be performed. Accordingly, a concise, efficient, scalable, 
and modular synthesis of trichodermamide B is highly desirable. 
 
1.3 Biosynthetic Proposal: Arene Oxides. 
The biosynthetic origin of trichodermamide B is unknown. However, we hypothesize that 
trichodermamide B is synthesized in vivo from a nucleophilic opening of an epoxidized 
phenylalanine derivative (an arene oxide) (Figure 4). It is known that many types of fungi possess 
mono- and dioyxgenases: enzymes that can directly epoxidize arenes to the corresponding arene 
oxide species.10 By intercepting such intermediates, we can access entire classes of bioactive 
natural products in a rapid, biomimetic fashion. 
  
 
 
 
Arene oxides are synthetically very attractive intermediates, as they are simple structures 
containing epoxides and olefins, two of the most versatile functional groups in organic chemistry. 
If these species could be prepared and derivatized using classical olefin and epoxide chemistry, 
they could be rapidly converted into wide libraries of diversely functionalized molecules. 
Unfortunately, such intermediates are not readily accessible to contemporary chemists. The first 
challenge to arene oxide chemistry is simply their formation. While nature can produce these 
intermediates through the direct epoxidation of arenes, this is not easily reproduced in the hood, 
due to the significant resonance stabilization energy of arenes, as well as the instability of these 
Figure 4. Proposed biosynthesis of trichodermamide B. 
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intermediates.11-13 Instead, the chemical synthesis of arene oxides involves many more steps and 
relatively harsh conditions. Frequently arene oxide syntheses require electronically biased 
systems, which lower the degree of aromaticity in the system, thus decreasing the energetic barrier 
for breaking the aromatic ring. The two most common strategies for preparing arene oxides involve 
elimination of leaving groups to form the diene on an already epoxidized ring, or an SN2 
displacement of a leaving group to form the epoxide on a cyclohexadiene system, as shown in 
Figure 5.14,15 
 
 
 
 
 
 
 
 
The other major challenge to incorporating arene oxides into a synthetic strategy is the NIH 
shift.16 Many arene oxides are extremely unstable, and will rapidly undergo an NIH shift to regain 
aromaticity, forming phenol products.17,18 This is manifested in the extremely short half-life of 
benzene oxide, only two minutes. The mechanism of this pathway is depicted in Figure 6, which 
was elucidated using isotopically labelled naphthalene. 1-T-naphthalene 11 was oxidized by 
Figure 5. a) Elimination strategies to form arene oxides; b) SN2 strategies to form arene oxides. 
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heptatic monoxygenases, to form the 1,2-naphthalene oxide species 12, which was stable enough 
to be characterized. Exposure to dilute acid results in formation of the triturated naphthol. The 
mechanism of rearrangement was postulated to involve first the formation of a distinct ionic 
species which then collapses to form a ketone with a 1,2-hydride shift. Subsequent tautomerization 
yields the observed product 14.19 
 
1.4 Retrosynthetic Analysis. 
The challenge of synthesizing trichodermamide B lies in the functionally-rich left 
fragment, whereas the right half of the molecule, aminocoumarin 15, has already been prepared in 
three high-yielding steps from a known procedure, and can be simply appended to the rest of the 
molecule through an amide coupling (Figure 7).20,21 The more complex fragment possesses a 
formidable cis-oxazadecalin core with four contiguous stereocenters. Thus, attentions were 
focused on the rapid formation of the left fragment of trichodermamide B in a concise, modular 
fashion.  
 
Figure 6. Experimental evidence for the NIH shift. 
Figure 7. Trichodermamide B can be formed through a simple amide coupling of two fragments. 
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Retrosynthetic analysis revealed that ester 17 can be formed from key intermediate 16 via 
a hydroxyl-directed [4+2]–cycloaddition with singlet oxygen, followed by reduction with 
triphenylphosphine, and nucleophilic attack by a chloride anion (Figure 8).22 Diene 16 formally 
represents an arene oxide equivalent, as one could envision forming such a structure via the 
nucleophilic opening of an epoxide with an oxime, as outlined in the proposed biosynthesis of this 
natural product (Figure 4). As such, intercepting diene 16 would lend support to our biosynthetic 
hypothesis, and initial efforts were directed towards this intermediate.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Proposed singlet oxygen cascade to access fragment 17 from diene 16. 
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CHAPTER 2: PREVIOUS SYNTHESES OF TRICHODERMAMIDE B 
Due to their notable biological activities and interesting molecular architecture, there have 
been three successful completed syntheses of the trichodermamide natural products. Of particular 
note is that each of these syntheses apply very unique approaches to the closure of the key cis-
fused oxazadecalin ring. Furthermore, while all elegant and significant advances to the field, only 
the synthesis by Joullié et al. is asymmetric.20 Syntheses of the trichodermamides, specifically 
trichodermamide B, are reviewed below.   
 
2.1 Zakarian’s Synthesis of (±)-Trichodermamide B. 
Zakarian reported the first total synthesis of trichodermamide B in 2008.21 Setting a 
precedent that all subsequent approaches would follow, the Zakarian group disconnected the 
molecule at the central amide bond, leaving them to synthesize an oxazadecalin core and a separate 
aminocoumarin, to be coupled at a late stage. The synthesis commenced with a Diels-Alder 
cycloaddition between 3-benzyloxy-2,2-dimethoxy-3,5-cyclohexadienone, 20 (prepared in three 
steps from commercially available materials, Figure 9) and a vinylene carbonate.  Hydrolysis of 
carbonate 22 resulted in deprotection and complete inversion of stereochemistry at the alcohol 
neighboring the ketone, presumably proceeding through a retro-aldol mechanism to favor the more 
thermodynamically stable trans-diol 23 (Figure 10).  
 
 
 
Figure 9. Zakarian starting material synthesis. 
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A sequence involving protection, samarium diiodide mediated deoxygenation, and Wittig 
homologation established the carbon framework of the oxazadecalin core, which was taken 
forward in four straightforward steps to ester 29.  
Figure 10. Diels-Alder cycloaddition and hydrolysis/retro-aldol cascade. 
Figure 11. Synthetic sequence to bicyclic ester 29. 
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The Zakarian group was then poised to employ their key step, a nitrosation/oxaza-Cope 
rearrangement previously developed in their laboratory.23,24 Exposure of ester 29 to lithium 
diisopropylamide followed by trimethylsilyl chloride formed silyl ketene acetal 30 which upon 
treatment with isoamyl nitrite and titanium tetrachloride yielded an intermediate nitroester, which 
underwent the desired oxaza-Cope rearrangement upon warming to 0 °C (Figure 12). This key 
step, while rapidly forming the oxazadecalin moiety of trichodermamide B, required substantial 
optimization. Increasing the equivalents of Lewis acid substantially increased the conversion, 
however leading also to concomitant debenzylation. An optimal stoichiometry of 2.1 equivalents 
was determined, providing an overall 82% yield.  
 
With the skeleton of the oxazadecalin in place, the remaining transformations targeted 
allylic transposition of the protected allylic alcohol, chlorination, and amide bond formation. 
Desilylation and treatment with DDQ formed the benzylidene acetal 33, protecting two of the three 
alcohols present in the molecule. The remaining allylic alcohol was converted to selenide 34 with 
inversion of configuration according to the Grieco protocol. Exposure to hydrogen peroxide  
Figure 12. Key oxaza-Cope rearrangement to furnish the oxazadecalin core. 
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effected the oxidative transposition to establish the remaining alcohol of 2. Protection of the free 
alcohol was followed by hydrolysis of the methyl ester and EDC coupling with the pre-formed 
aminocoumarin 15 (Figures 13 through 15).  
 
 
Figure 13. Preparation of left fragment of trichodermamide B – pre-amide bond formation. 
Figure 14. Preparation of aminocoumarin 15. 
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Removal of the benzylidene acetal, mesylation, nucleophilic displacement with a chloride 
anion and subsequent deprotection completed the first racemic total synthesis of trichodermamide 
B in 22 linear steps and 2.8 % overall yield (Figure 16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. EDC coupling to link two fragments of trichodermamide B. 
Figure 16. Final steps to complete the first synthesis of racemic trichodermamide B. 
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2.2 Joullié Synthesis of Trichodermamide B. 
 Later in 2008, the Joullié group from the University of Pennsylvania published the first 
asymmetric synthesis of trichodermamide B, starting from the chiral pool material (-)-quinic acid 
43.20,25 Refluxing in 2,2-dimethoxypropane and benzene protected the syn-1,2-diol as the 
acetonide, while simultaneously forming the bridged lactone 44. Methanolysis of the lactone to 
the methyl ester and TBDPS protection yielded alcohol 46 with orthogonal protecting groups 
(Figure 17).  
 Reduction and mesylation afforded primary mesylate 48, which upon treatment with 
LiHMDS underwent an intramolecular nucleophilic displacement to spiroepoxide 49. Opening of 
epoxide 49 with lithiated acetonitrile and subsequent methanolysis provided the already cyclized 
lactone 51, as detailed in Figure 18. 
 
Figure 18. Preparation and cyclization of spirolactone 51. 
Figure 17. Beginning of the Joullié synthesis – protection of quinic acid 
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Silyl group deprotection and a second mesylation set the stage for elimination to olefin 54. 
Finally, α-oxidation, protection of the resulting alcohol, and acetonide deprotection yielded 
spirolactone 57 in 13 steps from (-)-quinic acid as a mixture of diastereomers (Figure 19).  
With intermediate 57 in hand, the Joullié group proceeded with epoxidation with 
trifluoroperoxyacetic acid to set the stage for the key intramolecular cyclization. The authors noted 
that epoxidation at this position was particularly challenging, and while not specified, it is likely 
that the diol needed to be unprotected in order to direct the epoxidation to come from the desired 
face. Reprotection of the diol as the acetonide, followed by a two-step reduction of lactone 59 led 
to the migration of the TBDPS protecting group to the primary alcohol. Subsequent Dess-Martin 
periodinane oxidation yielded ketone 61, as shown in Figure 20.  
Figure 19. Preparation and alpha-oxygenation to ene-diol 57. 
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 Treatment of ketone 61 with hydroxylamine formed the oxime in situ, which upon 
treatment with base underwent an intramolecular epoxide opening to form the key oxazadecalin 
core of trichodermamide B (Figure 21).20 A similar approach to the core had been described by 
Taylor and coworkers in 2007, to make related natural product-like compounds.26 
 
 
 
 A series of protections and deprotections yielded diol 64, to prepare for the upcoming 
Corey-Winter olefination, shown in Figure 22. While the Joullié group found that classical 
refluxing conditions for the Corey-Winter worked well, using microwave-assisted conditions 
increased the yield of 66 significantly.20  
Figure 20. Setting the stage for intramolecular cyclization to the oxazadecalin core of 
trichodermamide B. 
Figure 21. Cyclization to form the central core of trichodermamide B. 
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 Allylic oxidation conditions were screened. This step again proved challenging, this time 
due to the existence of two allylic positions prone to oxidation. Finally, treatment of 66 with excess 
CrO3/3,5-dimethylpyrazole gave enone 67 in low yields, only about 30% over two recycles. Luche 
reduction of enone 67 gave allylic alcohols 68 and 69 in a mixture of separable diastereomers. 
These diastereomers were separated and taken through independently, one towards  
Figure 22. Corey-Winter olefination to install key double bond present in the oxazadecalin core 
of 2. 
Figure 23. Final allylic oxidation and functional group manipulations to furnish all four 
stereocenters present around the oxazadecalin ring. 
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trichodermamide A and the other to trichodermamide B. The allylic alcohol was protected as the 
acetate, the primary silyl ether was deprotected, and the resultant alcohol oxidized to the carboxylic 
acid providing coupling partners 74 and 75 (Figure 23).  
 Acid 74 was coupled to aminocoumarin 15, synthesized using a slightly different, but much 
higher yielding, sequence than that of Zakarian (Figure 24). Global deprotection of 79 then 
afforded trichodermamide A, (Figure 25) while TBAF deprotection, mesylation, and nucleophilic 
substitution with a chloride anion completed the first asymmetric synthesis of trichodermamide B 
(Figure 26).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Joullié synthesis of aminocoumarin 15. 
Figure 25. Total synthesis of trichodermamide A. 
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2.3 Larionov Synthesis of Trichodermemaide B. 
 By far the most concise synthesis of trichodermamide B came out of the Larionov group 
at University of Texas at San Antonio.27 A tandem 1,2-1,4-addition of an α-C,O-bislithiated ethyl 
pyruvate oxime 83 into benzoquinone 82 rapidly constructs the 1,2-oxazadecalin core skeleton of 
the natural product in one step, depicted in Figure 27. However, they required a series of significant 
functional group manipulations and oxidation state changes in order to set the correct functionality 
around the oxazadecalin ring system.  
 
  
 
 
Figure 27. Larionov methodology for rapid access to 1,2-oxazadecalin core. 
Figure 26. Completion of Joullié’s and coworker’s asymmetric synthesis of trichodermamide B. 
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Their synthesis commenced from enone 84, which they subjected to modified Luche 
conditions to access allylic alcohol 85. These optimized Luche conditions were crucial in order to 
achieve high stereoselectivity of the alcohol using the KBH4, with the acetic acid additive 
suppressing allylic alcohol polymerization. Treatment with chloroethyl carbonate afforded allylic 
carbonate 86, which was converted to diene 87 with tetrakis and BTSA (Figure 28).  
 
 
Ester cleavage and peptide coupling with aminocoumarin 15 (prepared according to the 
Joullié procedure) joined the two halves of trichodermamide B together, leaving the Larionov 
group just a few clever oxidations away from their target molecule (Figure 29).  
 
Figure 28. Preparation of diene 87. 
Figure 29. Coupling the two fragments of trichodermamide B. 
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Directed epoxidation produced epoxide 90 in nearly quantitative yield. Interestingly, 
efforts to perform a palladium-mediated opening of the epoxide with phenylselenol proceeded with 
an undesired inversion of configuration. This was overcome by first forming the trans-
bromohydrin 91, which, upon treatment with phenylselenol and a proton sponge followed by 
tosylation, yielded the desired cis-selenotosylate 93 in a good overall yield. Oxidation of the 
phenylselenide induced a selenoxide [2,3]-sigmatropic rearrangement to install the final hydroxyl 
stereocenter of trichodermamide B. Finally, nucleophilic displacement of the tosylate furnished 
the target molecule in 14 linear steps and 16% overall yield, as shown in Figure 30. 
Figure 30. Completion of Larionov synthesis of trichodermamide B. 
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2.4 Conclusions. 
 Despite that this molecule has been synthesized previously by three other groups, none of 
these approaches have been able to prepare the material on a gram-scale, which is often necessary 
in order to perform the whole vault of biological studies. Additionally, there is still much confusion 
surrounding the biosynthesis of this class of molecules, and investigations to this end could lead 
to a better understanding of the role of this molecule in vivo. Thus, there is an unmet need for a 
concise, scalable, bioinspired synthesis of trichodermamide B. 
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CHAPTER 3: INITIAL STRATEGIES TOWARDS TRICHODERMAMIDE B 
3.1 Retrosynthetic Analyses. 
The union of the two pieces of trichodermamide B via amide bond formation has been well 
documented, and the planar α–amino lactone can be prepared in three steps from commercially 
available starting materials.20 With that in mind, we directed our attention to constructing the 
structurally intriguing left fragment. Retrosynthetic analysis revealed that ester 17 can be formed 
from key intermediate 16 via a [4+2]–cycloaddition with singlet oxygen, followed by reduction 
with triphenylphosphine, and nucleophilic attack by a chloride anion, as shown in Figure 8.22 To 
form this intermediate, we envisioned several routes starting from inexpensive, readily available 
starting materials (Figure 31).  
 
 
 
 
 
 
 
 
 
3.2 Alkylation of Cyclohexadiene. 
Our initial attempts towards key intermediate 16 involved direct alkylation of 
cyclohexadiene 96 using sulfamidate 95 as a masked α–amino ester (Figure 32). If successful, this 
process would yield 103, formally an isomerized Birch product of protected phenylalanine. 
Figure 31. Initial retrosynthetic disconnections. 
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Sulfamidate 95 was prepared from L-serine, a chiral pool starting material that was predicted to 
control the stereochemistry of a subsequent cyclization.28 A variety of different conditions were 
screened for the deprotonation of 96 to engage in the subsequent nucleophilic attack on the 
sulfamidate, including using n-BuLi at –40 °C and –78 °C, sec-BuLi at –78 °C, and n-BuLi 
followed by transmetallation to zinc. Under all reaction conditions, the only products isolated were 
found to be aromatized compounds.  
   
 
 
3.3 Alkylation of Benzene Oxide. 
With this in mind, we approached the disconnection from another angle: preparing the 
organozinc species of the Boc-serine methyl ester rather than forming a carbanion on 
cyclohexadiene. This route is detailed in Figure 33. Organozinc species 98 was prepared by 
methylating and Boc-protecting serine 104, followed by an Appel reaction to form the iodide, and 
zinc insertion.29 Subsequent transmetallation to copper and SN2’ alkylation of preformed benzene 
oxide 97 failed to produce desired compound 105, instead yielding a phenylalanine derivative.  
 
 
 
Figure 32. Attempts to directly alkylate cyclohexadiene. 
Figure 33. Attempts to alkylate pre-formed benzene oxide. 
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3.4 Functionalization Through Radical Decarboxylation.  
Observing that all efforts to alkylate unsubstituted cyclohexadiene and benzene oxide 
resulted in aromatized products, a new plan was devised involving radical coupling to form 
intermediate 110, rather than the previously employed alkylations. It has been shown that in certain 
systems, stabilized radicals can be generated through radical decarboxylative processes. Overman 
et. al. previously reported one such approach to radical decarboxylation, involving the formation 
of the ester 108, which upon irradiation with UV light undergoes a radical decarboxylation, 
releasing CO2 and a tertiary radical.30 Direct treatment with bis(silyloxy)enamine 109 would 
produce desired compound 110.31,32 Initial experiments demonstrated that we could generate ester 
108, however this route was abandoned due to the low-yielding alkylation (Figure 34).33,34  
 
3.5 Claisen Rearrangement Strategy. 
In parallel with the studies towards radical decarboxylation, we were investigating an 
alternative route that avoided direct alkylation, instead forming the intermediate 112 through a 
[3,3]–sigmatropic rearrangement (Figure 35). Diene 16 could be traced back to bromolactone 111 
through conditions established by the Ganem group.14 Bromolactone 111 could be synthesized via 
Figure 34. Attempted application of Overman radical decarboxylation to prepare intermediate 
110. 
NO O
O O
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hydrolysis, bromolactonization, and epoxidation of diene 112 the product of a Claisen 
rearrangement of α,βunsaturated ester 113. While 113 itself has not been reported, the 
corresponding alcohol has, and we envisioned tracing it back to benzoic acid 106, beginning with 
a Birch reduction.35,36  
 
Birch reduction of feedstock commodity chemical benzoic acid 106 provided 1,4-
dihydrobenzoic acid in high yields on decagram scales.37 Fischer esterification to methyl ester 107, 
followed by m-CPBA epoxidation afforded epoxide 114. Elimination with triethyl amine produced 
allylic alcohol 115, which was transformed into phosphonate 117 via a rhodium carbene 
insertion.35 Horner-Wadsworth-Emmons olefination with phosphonate 117 and formaldehyde 
provided key intermediate 113 for the Claisen rearrangement, albeit in low yields.36 Refluxing 
α,βunsaturated ester 113 in toluene overnight caused the Claisen rearrangement to occur, forming 
desired αketoester 118 (Figure 36).  
 
 
Figure 35. Claisen rearrangement strategy 
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Figure 36. Successful application of the Claisen rearrangement strategy to key intermediate 118. 
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CHAPTER 4: ENOLATE ALKYLATION STRATEGY 
 While investigating the Claisen rearrangement approach to trichodermamide B, we were 
experimenting in parallel with the direct alkylation of 1,4-dihydrobenzoate esters. As the previous 
route was proving both challenging and unscalable, we considered instead the direct alkylation of 
the enolate of 99 with αbromo oximoester 102 (Figure 37). Notably, to our knowledge, this would 
be the first example of this type of selective SN2 reaction on an αbromo oximoester such as 102. 
 
  
 
 
Formation of the lithium enolate of ester 99, followed by dropwise addition of αbromo 
oximoester 102 afforded the desired alkylation product in high yields. In one step, this alkylation 
accomplished in 77% yield what previously required more than five steps to provide milligram 
amounts of material, as demonstrated in Figure 38. 
 
 
 
 
We thus initiated our synthesis with the Birch reduction of benzoic acid 106 followed by 
esterification, to yield 1,4-dihydrobenzoate ester 120 (Figure 39). The trichloroethyl ester 
Figure 37. Proposed enolate alkylation strategy. 
Figure 38. Direct alkylation of 1,4-dihydrobenzoate esters vs. Claisen rearrangement protocol. 
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protecting group was chosen for ease and mildness of deprotection with zinc. Interestingly, typical 
esterification strategies such as reaction with carbodiimidazole (CDI) or 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) led to isomerization to the 1,3-diene, while reaction 
with trichloroethanol in sulfuric acid smoothly provided the desired ester in high yields. Alkylation 
of ester 120 with TBS-protected bromo-oximoester 102 and LHMDS afforded diene 121. This 
single transformation rapidly installed the remaining carbon atoms present in the target fragment 
of trichodermamide B, forming a congested all-carbon quaternary center in good yields. 
Subsequent epoxidation with meta-chloroperoxybenzoic acid (m-CPBA) produced epoxide 122 in 
a single  diastereomer, the structure of which was confirmed by X-ray crystallography, inset in 
Figure 39. 
 
 
 
 
 
   
 
Treatment of TBS-oxime 122 with TBAF was predicted to afford cyclized product 123, 
however surprisingly only spirocycle 124 was isolated, resulting from transesterification of the 
trichloroethyl ester with the deprotected oxime. While this result was unexpected, we proposed 
Figure 39. Synthesis of fragment 122, and crystal structure of 122, confirming the TBS-protected 
oxime is actually pointed toward the epoxide (E-oxime, rather than Z). It is depicted as is for 
structural clarity. 
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that spirocycle 124 could still be elaborated into key intermediate 16 via radical bromination and 
base-induced hydrolysis, decarboxylation, and elimination. Bromination proceeded smoothly to 
afford 125 in a diastereomeric mixture. Unfortunately, all elimination and decarboxylation 
attempts resulted in decomposition (Figure 40).  
 
Returning to epoxide 122, removal of the trichloroethyl protecting group prior to TBS-
deprotection would prevent the previously observed cyclization. Thus, sonication of epoxide 122 
with aqueous ammonium chloride and activated zinc provided free acid 126 in a rapid and mild 
manner. Bromolactonization cleanly afforded βlactam 127, poised for deprotection, elimination, 
and decarboxylation to intercept key intermediate 16. Again, however, the decarboxylative 
elimination to the diene proved fruitless, leading to decomposition (Figure 41).  
Figure40. Strategy for the collapse of spirocycle 124 to form 16. 
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Figure 41. Bromolactonization strategy for the formation of diene 16. 
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CHAPTER 5: DEAROMATIZATION WITH ARENOPHILES 
At this stage, a completely conceptually distinct approach to the oxazadecalin fragment of 
trichodermamide B was considered. Recently, our laboratory has developed a platform for the 
dearomative functionalization of arenes using photactivable small molecules – termed arenophiles 
– which undergo para-cycloaddition across aromatic rings. The bicyclic intermediate formed is 
extremely unstable and readily cycloreverts back to the starting arene at non-cryogenic 
temperatures, however it can be intercepted at cold temperatures, and undergoes classical olefin-
type chemistry. The functionalized cycloadduct can be cleaved to the cyclic hydrazine, which upon 
workup is oxidized to release dinitrogen and a cyclohexadiene product, formally representing the 
oxidation of a single olefin of an aromatic system (Figure 42).38 This methodology has the potential 
to allow for rapid elaboration of a simple arene to the densely oxygenated core of trichodermamide 
B (Figure 43).  
  
 
  
 
 
 
Figure 42. Formal dihydroxylation of arenes using MTAD, 4-methyl-1,2,4-triazoline-3,5-dione. 
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Benzyl acetate 131, a feedstock building block, was subjected to dearomative 
dihydroxylation with MTAD (4-methyl-1,2,4-triazoline-3,5-dione) as the arenophile, and osmium-
mediated dihydroxylation as the olefin functionalization strategy. Protection of the resulting diol 
as the acetonide 132 and subsequent cycloreversion afforded allylic alcohol 133. Exposure to 
singlet oxygen, and Co[TPP] induced collapse of the subsequent endoperoxide produced syn-bis-
epoxide 134.39 Oxidation with Dess-Martin Periodinane yielded aldehyde 135, poised for a 
Horner-Wadsworth-Emmons olefination with phosphonate 136 to generate silyl enol ether 137. 
From intermediate 137, we envisioned a simple sequence of deprotection, oxime formation, 
cyclization, and deoxygenation to furnish fragment 17. However, all attempts to deprotect 137 to 
the keto-ester resulted in unproductive epoxide opening to alcohol 139, as shown in Figure 44. 
Inspection of the proposed mechanism for this transformation indicated that this epoxide opening 
would be an unavoidable competing pathway in this system, and the route was reconsidered.  
Figure 43. Retrosynthetic proposal using MTAD. 
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Figure 44. Forward synthesis with arenophile strategy. 
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CHAPTER 6: MICROBIAL ARENE OXIDATION APPROACH TO 
TRICHODERMAMIDE B 
6.1 Introduction. 
Due to experimental complexity and low yields with the MTAD route towards 
trichodermamide B, we considered the possibility of taking a chemoenzymatic approach, preparing 
a new starting material via microbial arene oxidation. While still a dearomatization, microbial 
arene oxidation is set apart from previous dearomative transformations in that it is both 
enantioselective and extremely scalable, enabling the rapid preparation of hundreds of grams of 
enantiopure, value-added material.40 We envisioned that a practical and scalable synthesis of (-)-
trichodermamide B could be achieved starting from the cis-dihydrodiol product of microbial arene 
oxidation on benzoic acid. The only asymmetric synthesis of this natural product to date was 
completed in 2008 by the Joullié group, and while it stands as a truly impressive landmark 
synthesis, the step count of this linear sequence is prohibitively high and the yield prohibitively 
low for practical adaptation for industry or analog preparation.20 Thus, there is still an unmet need 
for a scalable, efficient, and modular synthesis of enantiopure trichodermamide B.  
 
6.2 Microbial Arene Oxidation Mechanism and Background. 
While it had been known for many years that the metabolism of benzoic acid by bacteria 
proceeded via catechol, little mechanistic insight had yet been provided by 1971, when Professors 
Albey M. Reiner and George D. Hegeman began investigating the process.41,42 Due to the inherent 
chemical complexity of the benzoic acid oxidation, it was suggested that there were many 
enzymatic steps involved, with the putative enyzmes being referred to as the benzoate oxidase 
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system. Using a mutant strain of Alcaligenes eutrophus, blocked at the sites marked in Figure  45, 
to probe the mechanism of benzoic acid metabolism, the authors observed a buildup of a previously 
unidentified compound. Through spectroscopic studies and analysis of the thermal decomposition 
products (phenol and salicylic acid), the compound was determined to have a skeletal structure of 
142, the formation of which could be imagined occurring through one of two pathways, depicted 
in Figure 46.   
 
 
 
 
 
Mass spectral analyses of the products obtained by incubating the bacteria under a mixed 
16O2 and 18O2 atmosphere (~ 1:1) demonstrated that both oxygen atoms incorporated into the 
product originate from the same molecule of O2, lending support to the proposed mechanism 
marked as path a. While these data imply that the two alcohols of the benzoic acid dihydrodiol 
142 must be in a cis relationship, this assumption was backed by experimental evidence through 
Figure 45. Enzymatic pathway for bacterial metabolism of benzoic acid. The crossed arrows 
represent bocked enzymes in the mutant strain of Alicaligenes eutrophus (also known as 
Ralstonia eutropha B9). 
Figure 46. Possible pathways for formation of 1,2-diol 142 as postulated by Reiner and 
Hegeman. 
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kinetic and colorimetric studies. The diol obtained reacted with sodium periodate at a rate 
comparable to that of cis-1,2-cyclohexadiol and much faster than the corresponding trans-1,2-
cyclohexadiol, and upon exposure to potassium triacetylosmate, formed the same deep orange 
color as the same reaction with cis-1,2-cyclohexadiol, while trans-1,2-cyclohexadiol remained 
almost colorless.41  
While Reiner and Hegeman were able to establish the relative stereochemistry of 142 as 
the cis diol, the absolute stereochemistry remained undetermined until 1995. In 1986, Ribbons et 
al. discovered that a different microbial strain, Pseudomonas putida U103, accumulated the cis-
diol intermediate in the same way; comparison of the [α]D values confirming that the two samples 
were the same enantiomer.43 Widdowson and Ribbons synthesized crystalline derivative 144, and 
through X-ray crystallographic analysis established the absolute (1S, 2R) configuration (Figure 
47).44  
 
  
 
 
These early reports piqued the interest of the chemical community, laying the foundations 
for subsequent decades of rigorous mechanistic investigations. Since the initial report, much 
attention has been paid to compound 143 and its mechanism of formation. Particularly the group 
of Prof. John D. Lipscomb at the University of Minnesota has performed a number of truly elegant 
Figure 47. Chemical derivatization of microbial arene oxidation product to a crystalline material, 
144, to allow for determination of absolute configuration via X-ray crystallography. 
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studies on the metabolism of benzoic acid, ultimately proposing the mechanistic scheme depicted 
in Figure 48.45-47   
 The O2 incorporated into the benzoic acid is activated at a mononuclear non-heme iron 
site, facilitated by electrons supplied by a neighboring Rieske iron-sulfur cluster comprised of a 
reductase (BZDR) and oxygenase (BZDO) subgroup. Lipscomb and coworkers report that the 
active site of the oxygenase enzyme is difficult to access by the substrate when it is oxidized (FeIII 
vs. FeII), however the cis-dihydroxylation occurs via oxygen bound in an FeIII iron-oxo 
peroxospecies. The reaction thus proceeds through a complicated pathway involving a peroxide 
shunt. When the mononuclear iron center is reduced, the active site for the enzyme is accessible. 
Thus, the cycle begins with mononuclear FeII species binding the organic substrate, which causes 
Figure 48. Mechanism of formation of 143, as deduced by Professor Lipscomb and coworkers. 
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the iron to shift from 6 to 5 coordinate, opening a coordination site to accept molecular oxygen. 
The binding of the molecular oxygen can only occur with the Rieske iron cluster reduced, via 
BZDR. As the oxygen binds, one electron from the Rieske cluster and one electron from the 
mononuclear iron are transferred, forming the reactive peroxo intermediate. This reoxidation of 
the Rieske cluster induces a conformational change that brings the substrate in proximity with the 
activated Fe-peroxo species, promoting the cis-dihydroxylation event to occur. Subsequent 
reduction of the mononuclear iron center releases the product. This process is tightly regulated by 
different enzyme states, and is highly dependent on electron transfer. In systems where no electron 
transfer is possible, the rate slows significantly, as the reaction is forced to proceed through an 
alternate pathway (inner cycle in Figure 48). When there is no electron transfer possible, the 
substrate binds to the enzyme in the incorrect oxidation state, which is comparatively extremely 
slow due to the conformation of the active site in that state. This limits the reaction rate to a single 
turnover, and is facilitated by the hydrogen peroxide shunt.47  
 This process of microbial arene oxidation transforms planar, aromatic compounds into 
value-added, enantiopure functionalized materials. As such, the products of microbial arene 
oxidation, specifically BZDO, have been widely explored as substrates in organic synthesis, with 
numerous applications to the total synthesis of complex natural products. The different types of 
transformations well-established to functionalize or derivatize 143 are summarized in Figure 49.48 
Much of this work has been championed by the labs of Myers, Lewis, and Hudlicky; some of the 
natural products synthesized from this key starting material are represented below, in Figure 50.49-
54  
40 
 
 
 
 
 
 
 
 
6.3 Application of Microbial Arene Oxidation to Trichodermamide B. 
Upon examining the reported methods for functionalizing dihydrodiol 143, it became 
evident that the selective functionalization of the olefin proximal to the carboxylic acid is quite 
challenging. This is likely due to the significant steric effect of the neighboring tetrasubstituted 
carbon, as well as the deactivating nature of the carboxylic acid. However, we postulated that a 
selective protection of the secondary alcohol could allow for directed functionalization, guided by 
the remaining free alcohol. To this end, we envisioned the retrosynthesis shown in Figure 51, 
wherein a series of stereospecific transformations would yield  
 
Figure 49. Types of reactions used to functionalize 143, the product of BZDO. 
Figure 50. Natural products and natural-product like molecules synthesized starting from 143. 
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ent-trichodermamide B. The initial disconnection was to cyclize the oxazadecalin core by  
nucleophilic opening of an epoxide by an oxime, which would arise from hydrogen atom transfer 
(HAT) on α,βunsaturated ester 145. α,βunsaturated-ester 145 was traced back to the 
corresponding tertiary ester 146 through a reduction and olefination with a stabilized Wittig 
reagent. Finally, epoxide 146 was envisioned to be formed from a protection of the secondary 
alcohol and directed epoxidation of the olefin closest to the ester.  
Previous synthetic efforts by the Myers group showed that epoxidation on free acid 143 
epoxidation would selectively occur as if directed by the secondary allylic alcohol to form epoxide 
147, while epoxidation of the acetonide protected diol would yield the stereoisomer 149. 
Epoxidation of the more hindered olefin required a series of reactions involving 
bromolactonization of the acetonide protected diol, followed by methanolysis to furnish epoxy-
ester 152 (Figure 52).40 However, to our knowledge, no studies have been performed on the 
epoxidation of the mono-protected alcohol, leaving the free tertiary hydroxyl group to direct 
epoxidation.  
With this in mind, we decided to begin our investigations with the tert-butyldimethylsilyl 
protected diol 153, due to ease of preparation and relative bulkiness of the silyl group. Mono-
protection proceeded smoothly in high yields using TBSCl and imidazole. However, subsequent  
Figure 51. Retrosynthetic analysis for the preparation of trichodermamide B starting from 
microbial arene oxidation of benzoic acid. 
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Figure 52. Known reactivity for the epoxidation of 143 and derivatives versus the desired 
reactivity for selectively epoxidizing the more sterically hindered olefin.  
Figure 53. Epoxidation of 153 with mCPBA affords the undesired constitutional isomer. 
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epoxidation gave a 10:1 mixture of constitutional isomers, favoring the undesired epoxide 155, 
shown in Figure 53. We postulated that increasing the steric bulk of the protecting group would 
block the undesired olefin.  
Protection of the diol methyl ester diol 157 as the triisopropylsilyl ether and subsequent 
epoxidation, however, again yielded an unproductive mix of constitutional isomers, favoring the 
undesired epoxide 158 (Figure 54).  
 
 
Another factor contributing to the disappointing regioselectivity could be that the more 
hindered olefin is deactivated by the electron withdrawing inductive effects of the adjacent ester. 
Installing the α,βunsaturated-ester at this earlier stage would further separate the desired site of 
epoxidation from the deactivating group, thereby decreasing the detrimental inductive effects. 
Treatment of ester 153 with DIBAl-H to access the aldehyde proved fruitless however, even when 
applied in significant excess (five equivalents). This lack of reactivity was attributed to the steric 
crowding around the ester, preventing the bulky reagent from accessing the carbonyl. Thus, we 
decided to follow a stepwise procedure to aldehyde 160. Reduction to the primary alcohol 161 was 
achieved with LiBH4, and a subsequent one pot oxidation and Wittig olefination afforded α,β-
unsaturated-ester 162 in 82% yield over two steps.55 Unfortunately, exposure to m-CPBA still 
provided the undesired constitutional epoxide isomer (Figure 55).  
Figure 54. Epoxidation of the TIPS-protected methyl ester 156 afforded a similarly disappointing 
regioselectivity, forming mostly the undesired constitutional isomer 157. 
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At this stage we began to investigate alternative approaches for functionalizing the more 
hindered double bond. One transformation that has been explored extensively in the literature is a 
[4+2]-cycloaddition with singlet oxygen and fragmentation.44,48 Bubbling oxygen through a cold 
solution of protected diene with a TPP photosensitizer under irradiation with visible light led to 
slow conversion to the endoperoxide. The oxygen-oxygen bond was cleaved to the corresponding 
diol with thiourea, providing the protected tetraol. Due to the inefficiency of the singlet oxygen 
cycloaddition on this system, different substrates were screened, including acetonide protected  
 
 
 
Figure 56. Singlet oxygen approach to functionalizing diene 143. 
Figure 55. Preparation and reactivity of α,β-unsaturated-ester 162. 
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diol 148, free diol 143, and α,βunsaturated-ester 162. Both acetonide 148 and diol 143 proved to 
be competent substrates for this reaction, with acetonide 148 more efficient than 153 or 143.  
Action of singlet oxygen on α,βunsaturated-ester 162 produced a complex mixture (Figure 56). 
Cleavage of the endoperoxide and bis-mesylation afforded sulfonate 165, which was 
deprotected to diol 166 upon exposure to concentrated HCl (Figure 57).  
  
 
It was prophesied that treatment of 166 with base would incur nucleophilic displacement 
of the two mesylate leaving groups to form the elusive bis-epoxide. Reaction of diol 166 with 
K2CO3 in methanol formed the mono-epoxide 167, but the second displacement did not readily 
occur. Energy minimization calculations provided some insight into the challenges associated with 
this transformation, revealing that while one leaving group was oriented in a suitable anti-
periplanar position from the neighboring nucleophile, the other is syn-clinal, providing poor orbital 
overlap for displacement. Heating the reaction mixture led to decomposition of the material. 
Alternatively, deprotection of the acetonide 164 prior to mesylation, or simply singlet oxygen and 
cleavage on diol 155 affords tetraol 169, raising the possibility of Mitsunobu-type activation with 
subsequent displacement. Investigations into forming epoxide 168 via nucleophilic displacement 
are ongoing (Figure 58). 
 
 
Figure 57. Mesylation and deprotection to activated tetraol 166. 
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While investigating different approaches towards the key syn-bisepoxide, we were testing 
HAT (Hydrogen Atom Transfer) conditions for the installation of the oxime moiety of the 
oxazadecalin core.56-59 A series of simple operations provided an efficient route to gram amounts 
of model system 175 (Figure 59).  
 
  
HAT conditions to form the requisite oxime on model 175 were screened, including a series 
of different metal catalysts, solvents, nitrite sources, and silanes, as summarized in Figure 60. 
Despite all efforts, on the acetate protected model system 175 we were unable to detect any oxime 
Figure 59. Synthesis of model system to test HAT conditions. 
Figure 58. Attempts to form syn-bisepoxide 168. 
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(176) formation. Rather, either fully reduced product 177 was formed, or the starting material was 
recovered. The fact that saturated compound 177 was a major product was promising, however, as 
its mechanism of formation would also proceed through HAT, with quenching of the stabilized 
radical with a hydrogen source instead of the nitrite. As Mukaiyama originally reported, HAT is 
frequently very substrate specific, with steric bias playing a large role in the efficiency of HAT 
transformations.56-58 Running the reaction with less bulky nitrite reagents (n-Bu rather than t-Bu) 
similarly yielded only hydrogenated product 177, indicating that the substrate itself was likely too 
hindered for the oxime to form.  
 
 
 
 
With this in mind, we deprotected the tertiary alcohol, reasoning that the less bulky 
hydroxyl could allow for the desired HAT pathway to be followed. Unfortunately, HAT on alcohol 
178 resulted in saturated lactone 180, as shown in Figure 61. This could be derived from a 
reversible hydrogen atom addition into α,βunsaturated-ester 178, which could form a small 
amount of Z-olefin in equilibrium with the E-olefin and the radical intermediate. The Z-olefin 
would then position the ester and the free alcohol in close proximity for lactonization. HAT on the 
much more accessible lactone olefin could then readily form saturated product 180. Alternatively, 
HAT hydrogenation of the olefin could proceed first, followed by lactonization to form 180.  
AcO
O
CO2Et
TM
RONO
silane
solvent
AcO
O
CO2EtAcO
O
CO2Et
N OH
TM catalysts: Co(acac)2, Mn(dpm)2, Fe(acac)3, Co(TPP), Co(salen)
RONO: R = tBu, iBu, isoamyl, nBu
solvent: iPrOH, CH2Cl2, hexanes,
silane: Et3SiH, PhSiH3, PhSi(OiPr)H2,
175 176
177
Figure 60. Conditions employed for the installation of the key oxime moiety via HAT. 
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As a control, we ran the HAT reactions on the cyclohexyl system 181, with no added bulk 
at the position gamma to the ester (Figure 62). Under a variety of conditions the desired oxime 182 
was formed, alongside the fully saturated product 183, with the best catalysts being Mn(dpm)2 and 
Co(TPP). This confirmed that HAT was a viable route for oxime installation, albeit in an extremely 
substrate specific manner. However, while the model systems each possessed a tertiary alcohol 
moiety, which presumably inhibited the radical from being quenched with the bulkier nitrite 
reagents rather than the small hydrogen donors, the actual substrate for this transformation will 
have an epoxide at that center instead. We envisioned that having the oxygen at that center 
constrained in the form of an epoxide could alter the sterics around the α,βunsaturated-ester 
enough for the reaction to proceed.  
 
 
To test this hypothesis, we revisited an intermediate previously synthesized for the MTAD 
approach to trichodermamide B. Performing a Wittig reaction rather than a Horner-Wadsworth-
Emmons on aldehyde 135 provided access to the racemic, dihydroxylated version of the exact 
intermediate that we are trying to intercept. Preliminary studies on syn-bisepoxide 184 show 
Figure 61. Attempts to use HAT to install an epoxide on deprotected model system 178. 
CO2Et
TM
RONO
silane
solvent
CO2Et
N
OH
CO2Et
+
181 182 183
Figure 62. HAT on cyclohexyl-derived model system, 181. 
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promise, with clear oxime formation (observed by 1H and 13C NMR). While no model is an 
adequate substitute for the real system, and each compound is unique, we are optimistic that these 
results will successfully translate to the microbial arene oxidation system (Figure 63).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 63. HAT on MTAD-derived model system. 
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CHAPTER 7: CONCLUSIONS AND FUTURE DIRECTIONS 
 Significant progress has been made towards the enantioselective total synthesis of 
trichodermamide B, using the microbial arene oxidation of benzoic acid as a key enantio-
determining first step. The feasibility of employing HAT to install the oxime and cyclize down to 
close the oxazadecalin core in a mild, functional group tolerant manner has been demonstrated on 
a very representative model system. Current efforts are directed towards closing tetraol 169 or 
activated tetraol 166 down to the syn-bisepoxide. Literature precedent shows that a DIBAl-H 
reduction of similarly hindered epoxy-esters to the aldehyde proceeds in good yields. Applying 
this on bisepoxide 168, followed by Wittig olefination would set the stage for HAT to cyclize the 
oxazadecalin core. Finally, nucleophilic opening of the remaining epoxide with a chloride anion 
and peptide coupling to the aminocoumarin will furnish trichodermamide B in a scalable, concise, 
and asymmetric fashion.  
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APPENDIX  
General Procedures 
All reactions were performed without rigorous drying of solvents or glassware unless 
otherwise noted. Dry tetrahydrofuran (THF) was obtained by passing commercially available pre-
dried, oxygen-free formulations through activated alumina columns. Yields reported are of 
chromatographically and spectroscopically (1H NMR) homogenous materials. Reagents were 
purchased and used without further purification unless otherwise noted.   
1H NMR and 13C NMR were recorded on a Varian Unity 400/500 MHz (100/125 MHz 
respectively for 13C), a Bruker 500 MHz CryoProbe, or a VXR-500 MHz spectrometer. Spectra 
were referenced using CDCl3 as solvents with the residual solvent peak as the reference (1H NMR: 
δ 7.26 ppm, 13C NMR: δ 77.00 ppm for CDCl3). Chemical shifts were reported in parts per million 
and multiplicities are as indicated: s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). 
Coupling constants, J, are reported in Hertz and integration is provided.  
High-resolution mass spectra (HRMS) were recorded on a Micromass Q-Tof Ultima 
spectrometer using ESI (electrospray ionization). Infrared (IR) spectra were recorded on an ATR 
FT-IR spectrometer.  
Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25 mm E. 
Merck silica gel plates (60F-254) using UV light as visualizing agent and staining solutions of 
KMnO4 and PMA and heat as developing agents. E. Merck silica gel (60, particle size 0.040–0.063 
mm) was used for flash column chromatography.  
 
 
60 
 
Selected Experimental Procedures and Characterization 
 
Ester 120: 1,4-dihydrobenzoic acid 119 (725.4 mg, 5.84 mmol, 1.0 equiv) was 
dissolved in 2,2,2-trichloroethanol (7 mL, 72.63 mmol, 12.43 equiv). Sulfuric acid 
(0.5 mL, 9.38 mmol, 1.61 equiv) was added dropwise at room temperature with 
stirring. The reaction vessel was sealed with a yellow cap and allowed to stir at room 
temperature for 48 hours. The reaction mixture was quenched with NaHCO3 (sat. aq., 2 mL), and 
extracted with diethyl ether (4 x 20 mL). The combined organic layers were washed with brine 
and dried with anhydrous MgSO4. The filtrate was concentrated under reduced pressure, and the 
resulting oil was purified by flash column chromatography (silica gel, hexanes:EtOAc 20:1) to 
give ester 120 as a colorless oil (1.082g, 4.23 mmol, 72.5%).  
Rf = 0.42 (silica gel, hexanes:EtOAc 10:1) 
IR (ATR, neat, cm-1) 1751, 1449, 1422, 1368, 1313, 1084, 985, 961, 939, 893, 821, 620, 458  
1H NMR (CDCl3, 400 MHz) δ = 5.94 (dtd, J = 8.6, 3.4, 1.7 Hz, 2H), 5.86 (ddt, J = 10.5, 3.7, 1.9 
Hz, 2H), 4.76 (s, 2H), 3.88 (m, 1H), 2.71 (m, 2H)  
13C NMR, (CDCl3, 100 MHz) δ = 171.10, 127.41, 121.40, 95.13, 74.37, 41.69, 26.  
HRMS (ESI-TOF, m/z) calcd for C9H9O3Cl3 [M+Na]+ 253.9669, found 253.9659. 
 
Bromide 102: Ethyl bromopyruvate (8.43 mL, 67.0 mmol, 1.0 equiv), DCM 
(300 mL), and TBS-hydroxylamine (9.87 g, 67.0 mmol, 1.0 equiv), pyridinium 
p-toluenesulfonate (100 mg, 0.40 mmol, 0.6 mol%), and 4Å mol sieves (100 mg) 
were added to a flask. The round-bottom flask was covered with a yellow cap, sealed with 
parafilm, and wrapped in aluminum foil. The mixture was allowed to stir at room temperature for 
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48 hours. The solution was diluted with DCM (200 mL) and filtered over celite. The filtrate was 
washed with NaHCO3 (sat., aq.) (300 mL). The aqueous layer was extracted with DCM (3 x 100 
mL). The combined organics were washed with brine, dried over MgSO4 and filtered. The 
resulting oil was purified by flash column chromatography (silica gel, hexanes:EtOAc 20:1 to 
5:1) to give bromide 102 as a colorless oil (18.24 g, 56.3 mmol, 84%). 
Rf = 0.70 (silica gel, hexanes:EtOAc 5:1) 
IR (ATR, neat, cm-1) 1722, 1332, 1253, 1224, 1181, 1013, 987, 833, 785, 686 
1H NMR (CDCl3, 500 MHz) δ = 4.33 (q, J = 7.0 Hz, 2 H), 4.23 (s, 2 H), 1.35 (t, J = 7.0 Hz, 3 H), 
0.97 (s, 9 H), 0.25 (s, 6 H). 
13C NMR, (CDCl3, 25 MHz) δ = 162.5, 152.5, 62.1, 25.9, 18.2, 16.2, 14.2, –5.2.  
HRMS (ESI-TOF, m/z) calcd for C11H23NO3BrSi [M+Na]+ 324.0631, found 324.0631. 
 
Diene 121: A flame-dried, 200 mL round-bottom flask under a nitrogen 
atmosphere was charged with THF (50 mL) and HMDS (1.65 mL, 7.86 mmol, 
1.3 equiv). This solution was cooled to -78 ̊C. n-BuLi (4.53 mL, 7.86 mmol, 1.3 
equiv) was added dropwise. The reaction mixture was let stir for fifteen minutes. 120 (1.54 g in 2 
mL THF, 6.04 mmol, 1.0 equiv) was added dropwise, and the resulting solution was allowed to 
stir for thirty minutes. 102 (1.96 g in 2 mL THF, 6.04 mmol, 1.0 equiv) was added dropwise. 
This solution was allowed to stir for one hour before quenching with NH4Cl (sat. aq., 15 mL). 
The layers were separated, and the aqueous layer was extracted with ether (3 x 10 mL). The 
combined organics were dried over MgSO4 and concentrated. The resulting oil was purified by 
flash column chromatography (silica gel, hexanes:EtOAc 25:1) to give diene 12 (1.58 g, 3.14 
mmol, 52% yield).  
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Rf = 0.60 (silica gel, hexanes:EtOAc 5:1) 
IR (ATR, neat, cm-1) 1747, 1721, 1185, 1138, 992, 967, 837, 781, 715, 686 
1H NMR (CDCl3, 400 MHz) δ = 5.83 (m, 4 H), 4.75 (s, 2 H), 4.23 (q, J = 7.1 Hz, 2 H) 3.24 (s, 2 
H), 2.59 (m, 2 H), 1.30 (t, J = 7.1 Hz, 3 H), 0.95 (s, 9 H), 0.19 (s, 6 H).  
13C NMR, (CDCl3, 125 MHz) δ = 172.1, 164.8, 153.8, 126.9, 125.6, 95.1, 74.5, 61.6, 47.9, 33.6, 
26.2, 26.0, 18.2, 14.3, –5.0. 
HRMS (ESI-TOF, m/z) calcd for C20H30NO5SiCl3 [M+Na]+ 520.0843, found 520.0857. 
 
Epoxide 122: 121 (768 mg, 1.40 mmol, 1.0 equiv) was dissolved in DCM (16 
mL). The flask was cooled to 0 °C. NaHCO3 (647 mg, 7.00 mmol, 5.0 equiv) 
was added followed by m-CPBA (414 mg, 70% pure, 1.68 mmol, 1.2 equiv). 
The round –bottom flask was allowed to warm to room temperature, and the mixture was stirred 
for 48 hours. The reaction was quenched with saturated aqueous Na2S2O3 (8 mL). H2O (15 mL) 
was added to dissolve the white solid. The layers were separated and the aqueous layer was 
extracted with DCM (3 x 10 mL). The combined organics were dried over MgSO4 and filtered. 
Flash chromatography (20:1 Hex/EtOAc to 8:1 Hex EtOAc) gave 122 as a colorless solid (299 
mg, 43% yield) and recovered starting material (391 mg, 51%).  
Rf = 0.50 (silica gel, Hex/EtOAc 5:1) 
IR (ATR, neat, cm-1) 1753, 1720, 1253, 1197, 978, 910, 837, 785, 730, 687 
1H NMR (CDCl3, 500 MHz) δ = 5.71 (m, 1H), 5.48 (m, 1 H), 4.83 (d, J = 2.2 Hz, 2 H), 4.24 (m, 
2 H), 3.67 (m, 1 H), 3.40 (d, J = 12.5 Hz, 1 H), 3.23 (m, 1 H), 3.16 (d, J = 12.5 Hz, 1 H), 2.51 
(m, 1 H), 2.34 (dq, J = 19.5, 2.4 Hz, 1 H), 1.31 (t, J = 12.5, 3 H), 0.95 (s, 9 H), 0.20 (d, 6 H).  
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13C NMR, (CDCl3, 125 MHz) δ = 171.0, 164.3, 152.8, 123.6, 123.3, 94.8, 74.5, 61.7, 55.6, 51.4, 
48.3, 30.3, 26.0, 24.7, 18.2, 14.2, -5.0, -5.1. 
HRMS (ESI-TOF, m/z) calcd for C20H31NO6SiCl3 [M+Na]+ 514.0986, found 514.099 
 
Spirocycle 124: To a 4 mL vial was epoxide 122 (30 mg, 0.058 mmol, 1.02 
equiv), and DCM (580 μL). To this vial was added TBAF•3H2O (15 mg, 
0.057 mmol, 1.0 equiv) in a single portion. This solution was allowed to stir at 
room temperature for thirty minutes. The reaction was quenched by addition of NH4Cl (sat., aq.). 
The layers were separated and the aqueous layer was extracted with DCM (3 x 500 μL). The 
combined organics were dried over MgSO4 and concentrated. Flash chromatography (2:1 
Hex/EtOAc) gave 124 as an oil (9.6 mg, 0039 mmol, 68%). 
Rf = 0.60 (silica gel, Hex/EtOAc 1:1) 
IR (ATR, neat, cm-1) 1774, 1714, 1281, 1142, 993, 935, 916, 859, 815, 692 
1H NMR (CDCl3, 500 MHz) δ = 5.97 (d, J = 9.4 Hz, 1 H), 5.30 (d, J = 9.4 Hz, 1H), 4.99 (s, 1 H), 
4.36 (q, J = 7.2 Hz, 2 H), 4.00 (d, J = 5.6, 1 H), 2.97 (d, J = 18.6 Hz, 1 H), 2.77 (d, J = 18.6 Hz, 
1 H), 2.65 (d, J = 20.1 Hz, 1 H), 2.55 (d, J = 20.1, 1 H), 1.38 (t, J = 7.2 Hz, 3 H). 
13C NMR, (CDCl3, 125 MHz) δ = 172.3, 162.7, 148.4, 130.8, 123.8, 75.2, 72.0, 62.8, 38.7, 29.7, 
27.0, 14.4 
HRMS (ESI-TOF, m/z) calcd for C12H14NO5 [M+Na]+ 252.0872, found 252.0861 
 
Allylic bromide 125: To a 4 mL vial was added spirocycle 124 (45 mg, 
0.18 mmol, 1.0 equiv), dichlorobenzene (1.8 mL), NBS (35 mg, 0.20 
mmol, 1.1 equiv), and AIBN (6 mg, 0.036 mmol, 0.2 equiv). The vial was 
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sealed with a septa screw cap. This solution was heated to 90 °C for four hours. The solution was 
allowed to cool to room temperature. The reaction mixture was filtered over a celite, and purified 
via flash column chromatography (SiO2, 4:1 Hex/EtOAc) to give 125 (6.1 mg, 10% yield).  
Rf = 0.40 (silica gel, Hex/EtOAc 3:2) 
IR (ATR, neat, cm-1) 1794, 1717, 1280, 1258, 1137, 1004, 979, 940, 794, 738. 
1H NMR (CDCl3, 400 MHz) δ = 6.07 (dt, J = 9.5, 2.3 Hz, 1 H), 5.40 (dt, J = 9.5, 2.3 Hz, 1H), 
5.11 (dt, J = 5.8, 2.2 Hz, 1 H), 4.96 (q, J = 2.5 Hz, 1 H), 4.36 (q, J = 7.2 Hz, 2 H), 4.11 (dt, J = 
5.8, 1.2 Hz, 1 H), 3.03 (d, J = 18.8 Hz, 1 H), 2.77 (d, J = 18.8 Hz, 1 H), 1.37 (t, J = 7.1 Hz, 3 H). 
13C NMR, (CDCl3, 125 MHz) δ = 171.0, 162.4, 148.7, 132.7, 125.4, 77.9, 74.7, 63.1, 41.6, 38.4, 
29.2, 14.3. 
HRMS (ESI-TOF, m/z) calcd for C12H13NO5Br [M+Na]+ 329.9977, found 329.9969 
 
Silyl protected diene diol 153: To a 200 mL recovery flask equipped with a 
stirbar was added methyl ester 155 (1.00 g, 5.88 mmol, 1.0 equiv) dissolved in 
dichloromethane (60 mL), followed by NaHCO3 (4.94 g, 58.8 mmol, 10 equiv), 
and TBSCl (1.77 g, 11.8 mmol, 2.0 equiv). The flask was capped with a rubber septum, and 
stirred at room temperature overnight. Upon completion (as indicated by TLC), the reaction 
mixture was cooled to 0 °C, and quenched with a NaHCO3 solution (10 mL, sat. aq.). The layers 
were separated and the remaining aqueous layer was extracted with DCM (3 x 10 mL). The 
combined organics were dried over MgSO4 and concentrated. Flash chromatography (8:1 
Hex/EtOAc) gave 153 as a colorless oil (1.54 g, 5.41 mmol, 92%). 
Rf = 0.46 (silica gel, Hex/EtOAc 4:1) 
IR (ATR, neat, cm-1) 3546, 3051, 2954, 2930, 2887, 2858, 2711, 1742, 1472, 1463, 1436, 1390. 
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1H NMR (CDCl3, 500 MHz) δ 6.16 (dd, J = 9.5, 5.2 Hz, 1H), 5.96 (dddd, J = 9.5, 5.2, 2.7, 1.1 
Hz, 1H), 5.84 (dd, J = 9.5, 1.1 Hz, 1H), 5.75 – 5.69 (m, 1H), 5.04 – 4.96 (bs, 1H), 3.84 (s, 3H), 
3.43 (s, 1H), 0.93 (s, 9H), 0.15 (s, 3H), 0.07 (s, 3H). 
13C NMR, (CDCl3, 125 MHz) δ = 175.2, 131.9, 126.6, 124.8, 122.5, 74.6, 72.7, 52.9, 25.6, 17.9, 
-4.4, -5.2. 
HRMS (ESI-TOF, m/z) calcd for C14H23O4Si [M+Na]+ 307.1342, found 307.1339 
[α]D23.5 = 7.04° 
 
Acetonide protected tetraol 164: To a large pyrex test tube was added diene 148 
5(80 mg, 0.38 mmol, XX equiv) dissolved in dichloromethane (10 mL), followed 
by tetraphenylporphyrin (5 mg, 7.6 µmol, 0.02 equiv). A gas dispersion tube fitted 
to a tank of oxygen was submerged into the solution, set to slowly bubble oxygen through the 
reaction mixture. A series of six lamps (4W LED corn bulbs, 12V, cool white light 6500K, wired 
to a 12V power supply, then sealed into test tubes and capped with septa) were arranged around 
the reaction flask. The reaction setup was placed in an ice bath and cooled to 0 °C. The lights 
were turned on, and the reaction mixture was irradiated for 16 hours. The solution was 
concentrated down via under reduced pressure. The resulting red oily mixture was redissolved in 
MeOH (4 mL) and transferred to a 20 mL scintillation vial equipped with a stirbar. Thiourea (35 
mg, 0.46 mmol, 1.2 equiv) was added, and the reaction mixture was capped and stirred at room 
temperature overnight. Upon complete conversion (as observed by TLC), the solvent was 
removed under reduced pressure. The resulting solid was purified via flash column 
chromatography (SiO2, 1:2 Hex/EtOAc) to afford 164 as a thin film (41 mg, 0.38 mmol, 44%). 
Rf = 0.45 (silica gel, Hex/EtOAc 1:3) 
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IR (ATR, neat, cm-1) 3359, 2992, 2956, 2255, 2083, 1735, 1633, 1455, 1437, 1377. 
1H NMR (CDCl3, 500 MHz) δ 6.18 (m, 2H), 4.82 (d, J = 3.3 Hz, 1H), 4.41 – 4.30 (m, 2H), 3.86 
(s, 3H), 3.12 (d, J = 8.1 Hz, 1H), 2.93 (d, J = 5.6 Hz, 1H), 1.43 (s, 3H), 1.35 (s, 3H). 
13C NMR, (CDCl3, 125 MHz) δ = 172.6, 131.9, 131.1, 110.5, 85.5, 80.7, 69.5, 66.9, 52.9, 27.0, 
25.4. 
HRMS (ESI-TOF, m/z) calcd for C11H16O6 [M+Na]+ 267.0845, found 267.0843 
[α]D23.3 = 3.24° 
 
 Bis-mesylate 165: To a 10 mL recovery flask equipped with a stirbar was added 
164 (50 mg, 0.20 mmol, 1.0 equiv) dissolved in dichloromethane (2.0 mL). The 
flask was capped with a septum, put under an atmosphere of nitrogen, and cooled 
to 0 °C. Et3N (200 µL, 1.43 mmol, 7.0 equiv) was added, followed by MsCl (40 µL, 0.51 mmol, 
2.5 equiv). The reaction mixture was warmed slowly to room temperature and allowed to stir 
overnight. Upon completion, the reaction mixture was quenched with NaHCO3 (sat. aq.). The 
layers were separated, and the aqueous layer extracted with DCM (3 x 5 mL). The combined 
organic layers were dried over anhydrous MgSO4, concentrated under reduced pressure, and 
purified via flash column chromatography (SiO2, 2:1 Hex/EtOAc) to afford 165 as a colorless 
foam (74 mg, 0.18 mmol, 90%). 
Rf = 0.33 (silica gel, Hex/EtOAc 1:1) 
IR (ATR, neat, cm-1) 3031, 2994, 2942, 1757, 1742, 1438, 1415, 1359, 1256, 1225. 
1H NMR (CDCl3, 500 MHz) δ 6.08 (dt, J = 4.3, 1.4 Hz, 1H), 5.22 – 4.96 (m, 1H), 4.70 (dd, J = 
4.3, 1.4 Hz, 1H), 3.83 (s, 3H), 3.15 (s, 3H), 1.55 (s, 3H), 1.41 (s, 3H). 
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13C NMR, (CDCl3, 125 MHz) δ = 169.3, 129.0, 127.5, 112.4, 83.5, 79.8, 79.3, 76.9, 53.2, 39.0, 
38.8, 27.4, 27.3, 25.5. 
HRMS (ESI-TOF, m/z) calcd for C13H20O10S2 [M+Na]+ 423.0396, found 423.0394 
[α]D22.7 = 0.85° 
 
Bisepoxide 184: To a 200 mL recovery flask equipped with a stirbar 
was added aldehyde 135 (1.2 g, 5.7 mmol, 1.0 equiv) dissolved in 
dichloromethane (57 mL). At 0 °C preformed Wittig salt (3.94 g, 11.3 
mmol, 2.0 equiv) was added portionwise with stirring. The reaction vessel was capped with a 
septum, placed under an atmosphere of nitrogen, and let slowly warm to room temperature 
overnight. Upon completion, the reaction was quenched with NH4Cl (sat., aq.), and the layers 
were separated. The aqueous layer was extracted with DCM (3 x 20 mL). The combined organic 
layers were dried over anhydrous MgSO4, concentrated under reduced pressure, and purified via 
flash column chromatography (SiO2, 6:1 Hex/EtOAc) to afford 184 as a colorless oil (1.57 g, 5.6 
mmol, 98%). 
Rf = 0.37 (silica gel, Hex/EtOAc 4:1) 
IR (ATR, neat, cm-1) 2988, 2928, 1720, 1659, 1456, 1383, 1372, 1304, 1265, 1245. 
1H NMR (CDCl3, 500 MHz) δ = 7.08 (d, J = 15.7 Hz, 1H), 6.22 (d, J = 15.7 Hz, 1H), 4.55 (dd, J 
= 6.3, 1.0 Hz, 1H), 4.47 (dd, J = 6.3, 1.0 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 3.63 (d, J = 3.5 Hz, 
1H), 3.35 (dd, J = 3.5, 1.0 Hz, 1H), 3.11 (d, J = 1.0 Hz, 1H), 1.45 (s, 3H), 1.42 (s, 3H), 1.34 (t, J 
= 7.1 Hz, 3H). 
13C NMR, (CDCl3, 125 MHz) δ = 165.5, 143.4, 123.4, 110.3, 71.5, 70.7, 60.9, 59.3, 54.6, 50.9, 
49.7, 27.4, 25.2, 14.2. 
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HRMS (ESI-TOF, m/z) calcd for C14H18O6 [M+Na]+ 305.1001, found 305.0998 
NMR Spectra (1H and 13C) 
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